Can estimates of antimalarial efficacy from field studies be improved?

Trends in Parasitology

Volumn 24, Issue 2, 2008, Pages 68-73

  Gatton, Michelle L ^a   Cheng, Qin ^a,b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; CHLOROQUINE; FANSIDAR; MEFLOQUINE;

ARTICLE; DRUG EFFICACY; DRUG MONITORING; DRUG TREATMENT FAILURE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; MALARIA; NONHUMAN; POLYMERASE CHAIN REACTION; REINFECTION; STATISTICAL ANALYSIS; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING;

ALLELES; ANIMALS; ANTIGENS, PROTOZOAN; ANTIMALARIALS; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE; GENE FREQUENCY; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; TREATMENT FAILURE; TREATMENT OUTCOME; VARIATION (GENETICS);

EID: 38349115370     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.11.003     Document Type: Article

References (23)

1. World Health Organization Guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108. 2006. World Health Organization (available at http://www.who.int/malaria/includes_en/whomalariapublications19982004.htm)
2. Snounou G., and Beck H.P. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today 14 (1998) 462-467
3. Cattamanchi A., et al. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am. J. Trop. Med. Hyg. 68 (2003) 133-139
4. Slater M., et al. Distinguishing recrudescences from new infections in antimalaria clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am. J. Trop. Med. Hyg. 73 (2005) 256-262
5. Chen N., et al. P. vivax relapses result from clonal hypnozoites activated at predetermined intervals. J. Infect. Dis. 195 (2007) 934-941
6. Imwong M., et al. Plasmodium vivax relapses usually result from activation of heterologous hypnozoites. J. Infect. Dis. 195 (2007) 927-933
7. Ranford-Cartwright L.C., et al. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans. R. Soc. Trop. Med. Hyg. 91 (1997) 719-724
8. Konate L., et al. Variation of Plasmodium falciparum msp1 block 2 and msp2 allele prevalence and of infection complexity in two neighbouring Senegalese villages with different transmission conditions. Trans. R. Soc. Trop. Med. Hyg. 93 Suppl 1 (1999) 21-28
9. Imwong M., et al. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar. J. 4 (2005) 20
10. Zakeri S., et al. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. Trop. Med. Int. Health 11 (2006) 729-737
11. Kim J.R., et al. Genetic diversity of Plasmodium vivax in Kolkata, India. Malar. J. 5 (2006) 71
12. Bonilla J.A., et al. Genetic diversity of Plasmodium vivax Pvcsp and Pvmsp1 in Guyana, South America. Am. J. Trop. Med. Hyg. 75 (2006) 830-835
13. Montoya L., et al. Plasmodium falciparum: diversity studies of isolates from two Colombian regions with different endemicity. Exp. Parasitol. 104 (2003) 14-19
14. Nyachieo A., et al. Plasmodium falciparum genotyping by microsatellites as a method to distinguish between recrudescent and new infections. Am. J. Trop. Med. Hyg. 73 (2005) 210-213
15. Anderson T.J., et al. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 17 (2000) 1467-1482
16. Alam M.T., et al. Extensive heterozygosity at four microsatellite loci flanking Plasmodium vivax dihydrofolate reductase gene. Mol. Biochem. Parasitol. 153 (2007) 178-185
17. Su X., and Wellems T.E. Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics 33 (1996) 430-444
18. Tami A., et al. Restricted genetic and antigenic diversity of Plasmodium falciparum under mesoendemic transmission in the Venezuelan Amazon. Parasitology 124 (2002) 569-581
19. Mugittu K., et al. Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop. Med. Int. Health 11 (2006) 1350-1359
20. Mueller I., et al. The population structure of Plasmodium falciparum and Plasmodium vivax during an epidemic of malaria in the Eastern Highlands of Papua New Guinea. Am. J. Trop. Med. Hyg. 67 (2002) 459-464
21. Arez A.P., et al. A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology 118 (1999) 347-355
22. Zakeri S., et al. Population structure analysis of Plasmodium vivax in areas of Iran with different malaria endemicity. Am. J. Trop. Med. Hyg. 74 (2006) 394-400
23. Brockman A., et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am. J. Trop. Med. Hyg. 60 (1999) 14-21